Liu et al. showed that elevated CEA before treatment and positive lymph node staging on magnetic resonance imaging were independent risk factors for synchronous distant metastasis in rectal cancer.[23] The combination of both risk factors could indicate patients at high risk and candidates for structured personalized treatment. Here, CEACAM5 is linked to rectal cancer.